Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

Citations Over TimeTop 1% of 2014 papers

Abstract

Angioedema is defined as localized and self-limiting edema of the subcutaneous and submucosal tissue, due to a temporary increase in vascular permeability caused by the release of vasoactive mediator(s). When angioedema recurs without significant wheals, the patient should be diagnosed to have angioedema as a distinct disease. In the absence of accepted classification, different types of angioedema are not uniquely identified. For this reason, the European Academy of Allergy and Clinical Immunology gave its patronage to a consensus conference aimed at classifying angioedema. Four types of acquired and three types of hereditary angioedema were identified as separate forms from the analysis of the literature and were presented in detail at the meeting. Here, we summarize the analysis of the data and the resulting classification of angioedema.

Related Papers

• → Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema(2011)18 cited
• → Preliminary results of a non-interventional single-center study evaluating the efficacy of long-term use of lanadelumab in routine clinical practice in the Russian Federation(2023)2 cited
• → Complement Component Analysis in Angioedema(1975)11 cited
• → P161 PROPHYLACTIC TREATMENT BURDEN: ASSESSMENT BY CAREGIVERS OF PATIENTS WITH HEREDITARY ANGIOEDEMA(2020)
• → EE681 Costs of Treating Acute Hereditary Angioedema (HAE) Attacks With C1 Inhibitors in Five Central and Eastern European Countries(2022)